𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic variability of proto-oncogenes for breast cancer risk and prognosis

✍ Scribed by Lidereau, Rosette; Mathieu-Mahul, Danièle; Escot, Chantale; Theillet, Charles; Champeme, Marie-Hélène; Cole, Stewart; Mauchauffe, Martine; Ali, Isidore; Amione, Jacques; Callahan, Robert; Larsen, Christian-Jacques

Book ID
122005664
Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
867 KB
Volume
70
Category
Article
ISSN
0300-9084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression and loss of heterozygosity of
Expression and loss of heterozygosity of c-met proto-oncogene in primary breast cancer
✍ Dr. Janos Nagy; James S. Clark; Alexander Cooke; Ailsa M. Campbell; James M. Con 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract The c‐met proto‐oncogene encodes the receptor to hepatocyte growth factor‐scatter factor (HGF‐SF), a mesenchyme‐derived cytokine with cell‐dissociating, invasion, and angiogenic properties. The expression of c‐met in breast cancer is the subject of controversy; 111 primary breast cancer

Ethnic differences in risk and prognosis
Ethnic differences in risk and prognosis factors for breast cancer
✍ Miguel A. Sanchez 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 2 views

provide little or no support of his concept. These include 1 ) the 1969 AFIP Fascicle on Tumors of the Peripheral Nervous System by Harkin and Reed,g wherein the term cellular schwannoma was used to denote a benign schwannoma, one cellular, exhibiting pleomorphism, both Antoni-A and B tissue, and on